Fourth quarter sales of filtration and specialty products were up 3% compared to the prior year. For the year, sales were up 10% with growth across all key application areas and the effect of foreign currency translation. Segment operating income in the quarter was 28% of sales, slightly below the 30% level last year, due to the cost of added PUREMA hemodialysis membrane capacity in 2011, which will allow us to participate in the industry growth going forward.

Read the rest of this transcript for free on seekingalpha.com

If you liked this article you might like

Charts Show 3M Sticking to Recovery Ahead of Earnings

Polypore International (PPO) Highlighted As Strong And Under The Radar Stock Of The Day

Today's Strong And Under The Radar Stock Is Polypore International (PPO)

Today's Strong And Under The Radar Stock Is Polypore International (PPO)

Polypore International (PPO) Is Today's Strong And Under The Radar Stock